Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10211)	5/8/2018 6:38:08 PM
From: HardToFind	Respond to of 12873

For the record, I DO think Diwan cares about NNVC and its shareholders succeeding. (It's just that it appears not to be as much as he cares about TheraCour, but NNVC's failure would certainly be a stain on his reputation. The story would be retold in unflattering terms in places like Seeking Alpha, a reputation that may dog him for the rest of his life. I think he doesn't want that.) From a business perspective I do NOT think he yet considers NNVC a success. No drugs have been approved or marketed. He may be happy with the progress the science has made, but I don't think he'd call the company as a financial venture a success. After all, this is not Kickstarter. This is the NYSE-Mkt, where success is measured by the rewarding of shareholders. I do not know if he considers himself to have managed the company well or not. I'll give him a nod for the science, but I think he needs help with the business side of things. I hope he agrees.